Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate-specific membrane antigen (PSMA) is a cell membrane glycoprotein that is selectively expressed in prostate cells, with expression levels increasing dramatically in prostatic adenocarcinoma. PSMA-based radioligand therapy (RLT) has emerged as a viable therapeutic modality for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Michael, Niaz, Muhammad O, Nelson, Adlai, Skafida, Myrto, Niaz, Muhammad J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392183/
https://www.ncbi.nlm.nih.gov/pubmed/32760622
http://dx.doi.org/10.7759/cureus.8921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392183/
https://www.ncbi.nlm.nih.gov/pubmed/32760622
http://dx.doi.org/10.7759/cureus.8921

Ejemplares similares